Belgium · 
What does Droia Ventures invest in?
Droia Ventures invests most often at Series B and Series A (88% of the rounds on record), in sectors such as Therapeutics, Oncology and Genetic Disease.
Droia Ventures highlights
- 01
4 cheques in the last 12 months
- 02
Mostly Series B and Series A: 88% of its rounds
- 03
Sole investor in 1 rounds, median $4.5M
What they do
Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- Not stated
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- TherapeuticsOncologyGenetic Disease
- Based in
- Zaventem, Belgium
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first8 appearances
- 2026
3 rounds
- Oct
- Aug
- Mar
- 2025
3 rounds
- Dec
- Mar
- Jan
- 2024
1 round
- Jun
- 2009
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
14 of 23 we have independently watched raise
Alesta TherapeuticsArcus BiosciencesAura BiosciencesCristal TherapeuticsCyteir TherapeuticsFrontier MedicinesHighlight TherapeuticsHillstarBio Hillstar Bio™Hummingbird BioscienceMahzi Therapeutics MahziMuna TherapeuticsQuralisUnnatural ProductsVaderis Therapeutics VaderisActio BiosciencesESG DisclosuresHyku Biosciences WithInvestor portalMontis BiosciencesOctimet translational acceleratorTusk Therapeuticsde maanstekerijprotego
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.